| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/02/2005 | EP1502949A1 Antimicrobial polypeptide and utizliation thereof |
| 02/02/2005 | EP1502116A2 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 02/02/2005 | EP1501862A2 Novel analogues of glucose-dependent insulinotropic polypeptide |
| 02/02/2005 | EP1501533A2 Peptide inhibitors of protein kinase c ϝ for pain management |
| 02/02/2005 | EP1501532A2 Peptide inhibitors of protein kinase c |
| 02/02/2005 | EP1372686B1 Methods and compositions for peptide synthesis |
| 02/02/2005 | EP1297175A4 Methods and compounds for modulating nuclear receptor coactivator binding |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/02/2005 | CN1187369C Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts |
| 02/01/2005 | US6849710 Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide |
| 02/01/2005 | US6849709 Aerothricin derivatives |
| 02/01/2005 | US6849602 Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
| 02/01/2005 | US6849601 A conotoxin proteins is adrenergic blocking agents, treating disorders of urinary or cardiovascular conditions, having alpha 1-adrenoceptor antagonist activity |
| 02/01/2005 | US6849596 Regulatory/unfolding peptides of ezrin |
| 02/01/2005 | US6849593 Bifidogenic peptides |
| 02/01/2005 | US6849438 Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 02/01/2005 | CA2248140C Assay and reagents for quantifying hbnp |
| 01/29/2005 | CA2445420A1 Kinase and phosphatase assays |
| 01/27/2005 | WO2005007844A1 Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| 01/27/2005 | WO2005007821A2 Tertiary structures of ica-1/lfa-1 modulators |
| 01/27/2005 | WO2005007685A1 Cylic polypeptides that can combine with rnaiii activating protein secreted by staphylococcus aureus and their medical use |
| 01/27/2005 | WO2005007684A1 Small molecule peptide to bind trap and their medicinal use |
| 01/27/2005 | WO2005007683A1 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use |
| 01/27/2005 | WO2005007682A2 A peptide and a pharmaceutical composition, and their medical applications |
| 01/27/2005 | WO2005007681A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/27/2005 | WO2005007198A2 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa |
| 01/27/2005 | WO2005007069A2 Soft gel formulations for saquinavir |
| 01/27/2005 | WO2004050851A3 Prion protein ligands and methods of use |
| 01/27/2005 | WO2003072600A3 Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53 |
| 01/27/2005 | US20050020811 Methods and compositions for the treatment of gastrointestinal disorders |
| 01/27/2005 | US20050020810 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 01/27/2005 | US20050020809 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/27/2005 | US20050020492 Melanin-concentrating hormone analogs |
| 01/27/2005 | US20050019826 Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof |
| 01/27/2005 | US20050019820 Reagents and methods useful for detecting diseases of the lung |
| 01/27/2005 | US20050019754 Peptides of given sequence with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/27/2005 | US20050019344 Antigens; vaccines; isolated peptide |
| 01/27/2005 | US20050019341 Gene that codes tumor antigen is detected by cytotoxic lymphocyte; isolated from Dna libraries |
| 01/27/2005 | CA2532664A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/27/2005 | CA2532013A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof |
| 01/26/2005 | EP1500662A2 Stabilizing peptides |
| 01/26/2005 | EP1499888A2 Conformationally constrained peptides that bind the orl-1 receptor |
| 01/26/2005 | EP1499886A1 Methods and compositions for inducing an immune response |
| 01/26/2005 | EP1499337A1 Immunotherapeutic and immunoprophylactic reagents |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499335A2 Chimeric hybrid analgesics |
| 01/26/2005 | EP1239867B1 Methods for treating and preventing damage to mucosal tissue |
| 01/26/2005 | EP1107981B1 Synthesis of ring-modified cyclic peptide analogs |
| 01/26/2005 | EP0996636B1 The ha-1 antigen |
| 01/26/2005 | EP0871486B1 Diphtheria toxin epitopes |
| 01/26/2005 | EP0579758B1 Parathyroid hormone receptor and dna encoding same |
| 01/26/2005 | CN1571795A Synthesis of cyclosporin analogs |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1569893A Antigen epitope of gold staphylococcus virulence factor regulatory protein and its mimic epitope and use thereof |
| 01/26/2005 | CN1569891A Micro-molecular polypeptides capable of combining with gold staphylococcus virulence factor regulatory protein and its pharmaceutical use |
| 01/26/2005 | CN1569890A Solid-phase synthesis process of octreotide acetate |
| 01/26/2005 | CN1569889A Cyclo-polypeptides capable of combining with autocrine RNAIII activator protein of gold staphylococcus and its pharmaceutical use |
| 01/26/2005 | CN1186353C 17 peptide organic compound and its application |
| 01/26/2005 | CN1186352C HAb18G(/CD147) peptide agonist and its prepn and use |
| 01/25/2005 | US6846806 Peptide inhibitors of Hepatitis C virus NS3 protein |
| 01/25/2005 | US6846805 Oligopeptides or polypeptides used to inhibit transmembrane proteases such as aspartyl secretases, administered for prophylaxis of neurodegenerative diseases; Alzheimer's disease |
| 01/25/2005 | US6846802 Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties |
| 01/20/2005 | WO2005005631A1 Hla-a24 binding cancer antigen peptide derived from ribin |
| 01/20/2005 | WO2005005463A1 Antifungal cyclic lipopeptides |
| 01/20/2005 | WO2005005462A2 Blys antagonists and uses thereof |
| 01/20/2005 | WO2005005436A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/20/2005 | WO2005004792A2 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 01/20/2005 | WO2004098627A9 Inhibition of platelet aggregation through acyclovir and two peptide antagonists |
| 01/20/2005 | WO2004073625A3 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 01/20/2005 | WO2004033479A3 Retroyclins: antiviral and antimicrobial peptides |
| 01/20/2005 | WO2004020466A8 Protein tyrosine phosphatase inhibitors |
| 01/20/2005 | US20050014696 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014685 Fungicide, microbiocide,glucanase inhibitor; therapy, prophylaxis of penumocystis infections in humans, animals |
| 01/20/2005 | US20050014684 Cycloheptatide; solid phase synthesis; anticancer agents |
| 01/20/2005 | US20050014138 Using mimetic peptide to generate immunoglobulins for treatment of infections, metabolic and cell proliferative disorders; immunotherapy; peptide therapy |
| 01/20/2005 | CA2526402A1 Blys antagonists and uses thereof |
| 01/20/2005 | CA2525091A1 Water-soluble shps as novel alkylating agents |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1498422A1 C5a Receptor Antagonists |
| 01/19/2005 | EP1497646A2 Peptide biomarker and method of identification |
| 01/19/2005 | EP1497452A2 Methods for measuring enzyme activity |
| 01/19/2005 | EP1497441A1 Synthetic transfer complex and method for transferring nucleic acids |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497318A2 Binding molecules for fc-region polypeptides |
| 01/19/2005 | EP1497314A2 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 01/19/2005 | EP1497313A2 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 01/19/2005 | EP1497282A2 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease |
| 01/19/2005 | EP1496935A2 Insulin and igf-1 receptor agonists and antagonists |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496929A1 Use of c5a receptor antagonist in the treatment of fibrosis |
| 01/19/2005 | EP1379283A4 Identification of target-specific folding sites in peptides and proteins |
| 01/19/2005 | CN1568329A Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 01/19/2005 | CN1568325A Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/19/2005 | CN1568306A Hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1185252C Somatostatin peptides |
| 01/19/2005 | CN1185251C Novel LHRH-antagonists with improved solubility characteristics |